Read Time: 3 minutes
Every year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty. This year, Natasha Pavlova, PhD, Benjamin Sanchez Terrones, PhD, Yang Liu, PhD, Ami B. Patel, MD and Djin L. Tay, PhD, RN received $30,000 from Institutional Research Grants. Principal investigator Don Ayer, PhD, says this money will be used to kickstart their research projects.
Learn more about the award recipients and their research.
Natasha Pavlova, PhD
Assistant professor of oncological sciences, researcher at Huntsman Cancer Institute
Pavlova's work focuses on the metabolism of the cell related to the growth of solid tumors.
“The metabolism process can provide nutrients to cancer cells. This nutrition helps cancer cells create more of themselves, causing cancer to grow and spread," says Pavlova. "Understanding this mechanism will help us design new treatments that restrict this process."
This grant will not only fund her research but build a foundation for larger research grants.
"Receiving this grant was a vote of confidence in my research plan," says Pavlova. "I am honored to receive this grant, and the institutional support that comes with it.”
Benjamin Sanchez Terrones, PhD
Assistant professor of electrical and computer engineering, member of the experimental therapeutics program at Huntsman Cancer Institute
Sanchez Terrones, a trained electrical engineer, and a former instructor at Harvard Medical School, has used his experience to guide his research.
“My background has given me the opportunity to witness, first-hand, how my skills can be used to help people,” says Sanchez Terrones.
Through his research, he has developed a device that can be used to detect, diagnose, stage, treat, and monitor skin cancer. Utah has the highest rate of melanoma in the nation. It is also one of the most common cancers in the Area we Serve, which includes Utah, Wyoming, Idaho, Nevada, and Montana.
With the support of this grant, Sanchez Terrones hopes to improve the limited tools that physicians have to evaluate skin lesions.
Yang Liu, PhD
Assistant professor of biochemistry, researcher at Huntsman Cancer Institute
Liu’s interest in cancer research started when stage IV lung cancer took away the life of his 68-year-old grandmother. His grandfather is currently undergoing treatment for prostate cancer.
“Losing a family member profoundly impacts your life,” says Liu. “Understanding cancer and developing effective cancer therapies will undoubtedly contribute to a better and healthier world.”
Liu is contributing to the development of effective cancer therapies by looking at the way cells detect and repair damaged DNA. When DNA is damaged and multiplies, cancer can develop and grow. Liu plans to use CRISPR technology, a gene-editing tool that can cut and alter DNA, to manipulate this process in hopes of finding new paths for precise and targeted treatments.
Ami B. Patel, MD
Division of hematology and hematologic malignancies at Huntsman Cancer Institute
Patel has been a part of Huntsman Cancer Institute since 2014. She is a physician-scientist who specializes in blood and bone marrow cancers.
“My motivation comes from the patients in my clinic and in the hospital, who I see facing each day with grace, dignity, and humor,” says Patel.
Her ACS project will focus on people who have developed both lymphoma and leukemia to see if they carry genetic differences in their blood stem cells.
“I am hopeful that my research can lead to improved quality of life and survival for patients diagnosed with myeloid leukemias,” says Patel.
Djin L. Tay, PhD, RN
Assistant professor in the college of nursing, researcher at Huntsman Cancer Institute
Tay’s work focuses on the relationship between mental health and the discontinuation of cancer treatment in her research.
“To our knowledge, this is the first causal model that looks at disparities, mental health comorbidity, and immune-related adverse event outcomes using a national dataset,” says Tay.
Tay hopes that this first step will ultimately result in more equitable cancer care.
“We live in a world where we have increased access to very large amounts of data. I am thankful to be a part of an academic community that is driven to use this information to improve outcomes for the populations we serve.”
Congratulations to these faculty on their awards.
Learn more about Huntsman Cancer Institute’s research.
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the University of Utah is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.